Evidence map›Paper›PMID 31183626›Full record

ArticleJournal of assisted reproduction and genetics2019

Is younger better? Donor age less than 25 does not predict more favorable outcomes after in vitro fertilization.

Leigh A Humphries, Laura E Dodge, Erin B Kennedy, Kathryn C Humm, Michele R Hacker, Denny Sakkas

Open access · greenAbstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Choice of statistical model in observational studies of ART.Human reproduction (Oxford, England) · 2020
    Article
  4. Euploid rates among oocyte donors: is there an optimal age for donation?Journal of assisted reproduction and genetics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Leigh A HumphriesDepartment of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, 330 Brookline Ave., KS 3, Boston, MA, 02215, USA.
Laura E DodgeDepartment of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, 330 Brookline Ave., KS 3, Boston, MA, 02215, USA.
Erin B KennedyDepartment of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, 330 Brookline Ave., KS 3, Boston, MA, 02215, USA.
Kathryn C HummDepartment of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, 330 Brookline Ave., KS 3, Boston, MA, 02215, USA.
Michele R HackerDepartment of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, 330 Brookline Ave., KS 3, Boston, MA, 02215, USA.
Denny SakkasBoston IVF, 130 2nd Ave, Waltham, MA, 02451, USA. dsakkas@bostonivf.com.ORCID http://orcid.org/0000-0002-9509-6791
Beth Israel Deaconess Medical Center · USBoston IVF · US

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
Harvard Catalyst Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award 1UL1 TR001102-01) and financial contributions from Harvard University and its affiliated academic health care centers.NCATS NIH HHS UL1 TR001102
6 · The paper itself

Abstract

objectiveTo determine whether younger oocyte donor age is associated with better outcomes after in vitro fertilization (IVF) compared with older oocyte donor age.

designA retrospective cohort study.

settingLarge academically affiliated infertility treatment center. PATIENTS: We included all women ≥ 18 years who started their first fresh cycle using donor oocytes at our center from January 2002 through October 2017; only the first oocyte recipient cycle was analyzed.

interventionLog-binomial regression was used to compare the incidence of clinical pregnancy and live birth among the following donor age groups: < 25 years, 25 to < 30 years, and 30 to <35 years.

main outcome measureIncidence of clinical pregnancy and live birth among donor age groups.

resultsWe included 774 donor cycles; 269 (34.8%) used donors < 25 years, 399 (51.6%) used donors 25 to < 30 years, and 106 (13.7%) used donors 30 to < 35 years. Median donor age was 26 years (range 18-34.5), and median recipient age and partner age were both 42 years. Per cycle start, after adjusting for recipient age, cycles using donors < 25 years were not associated with a higher incidence of clinical pregnancy (RR 0.90; 95% CI 0.77-1.06) or live birth (RR 0.87; 95% CI 0.72-1.04) compared with donors age 25-< 30 years.

conclusionsDonor age < 25 was not associated with better outcomes after IVF. Under the age of 30, the prioritization of <25 year old donors may not be recommended given the lack of evidence for superior pregnancy or live birth outcomes.

Indexed as

Birth RatePregnancy OutcomePregnancy RateAdolescentAdultAge FactorsFemaleFertilization in VitroHumansOocyte DonationPregnancyRetrospective StudiesYoung AdultAgeAssisted reproductive technologyIVFLive birthOocyte donation

Identifiers

PMID31183626
PMCPMC6708004
OpenAlexW2949880905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.